Broadfin Healthcare Master Fund Ltd's Form 4 filing
Biodelivery Sciences International Inc (BDSI) · filed Nov 22, 2021
- Accession no.
- 0001103021-21-000120
- Filed
- Nov 22, 2021, 7:37 AM ET
- Trade date
- Nov 19, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $306.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadfin Healthcare Master Fund LtdCIK 0001511900 | Director |
| Broadfin Capital, LLCCIK 0001511901 | Director |
| Kotler KevinCIK 0001601692 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | Common Stock | PPurchaseAcquired | +100,000 | $3.06 | +$306,000 | 5,158,489 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.